Issue navigation
Volume 60, Issue 1, January 2021
EDITORIALS
Kidney disease in eosinophilic granulomatosis with polyangiitis: expect the unexpected
Rheumatology, Volume 60, Issue 1, January 2021, Pages 1–2, https://doi.org/10.1093/rheumatology/keaa571
Treating rheumatoid arthritis to an imaging target produces better outcomes, or does it?
Rheumatology, Volume 60, Issue 1, January 2021, Pages 3–4, https://doi.org/10.1093/rheumatology/keaa659
Toxoplasmosis and treatment for rheumatic diseases: what are the risks?
Rheumatology, Volume 60, Issue 1, January 2021, Pages 5–7, https://doi.org/10.1093/rheumatology/keaa614
Ecce urate
Rheumatology, Volume 60, Issue 1, January 2021, Pages 8–10, https://doi.org/10.1093/rheumatology/keaa665
REVIEW ARTICLES
Takotsubo syndrome and rheumatic diseases—a critical systematic review
Rheumatology, Volume 60, Issue 1, January 2021, Pages 11–22, https://doi.org/10.1093/rheumatology/keaa504
Ankle arthritis – an important signpost in rheumatologic practice
Rheumatology, Volume 60, Issue 1, January 2021, Pages 23–33, https://doi.org/10.1093/rheumatology/keaa531
Mimics of vasculitis
Rheumatology, Volume 60, Issue 1, January 2021, Pages 34–47, https://doi.org/10.1093/rheumatology/keaa495
SYSTEMATIC REVIEW AND META-ANALYSIS
High-frequency follow-up studies in musculoskeletal disorders: a scoping review
Rheumatology, Volume 60, Issue 1, January 2021, Pages 48–59, https://doi.org/10.1093/rheumatology/keaa487
The risk of infections in adult patients with systemic lupus erythematosus: systematic review and meta-analysis
Rheumatology, Volume 60, Issue 1, January 2021, Pages 60–72, https://doi.org/10.1093/rheumatology/keaa478
Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis
Rheumatology, Volume 60, Issue 1, January 2021, Pages 73–80, https://doi.org/10.1093/rheumatology/keaa655
Systematic review and meta-analysis of epidemiological studies on the association of occupational exposure to free crystalline silica and systemic lupus erythematosus
Rheumatology, Volume 60, Issue 1, January 2021, Pages 81–91, https://doi.org/10.1093/rheumatology/keaa444
CLINICAL SCIENCE
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis
Rheumatology, Volume 60, Issue 1, January 2021, Pages 92–102, https://doi.org/10.1093/rheumatology/keaa164
Early detection of ventricular dysfunction in juvenile systemic sclerosis by speckle tracking echocardiography
Rheumatology, Volume 60, Issue 1, January 2021, Pages 103–107, https://doi.org/10.1093/rheumatology/keaa208
Patient adherence with a smartphone app for patient-reported outcomes in rheumatoid arthritis
Rheumatology, Volume 60, Issue 1, January 2021, Pages 108–112, https://doi.org/10.1093/rheumatology/keaa202
Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe
Rheumatology, Volume 60, Issue 1, January 2021, Pages 113–124, https://doi.org/10.1093/rheumatology/keaa181
Translating research into clinical practice: quality improvement to halve non-adherence to methotrexate
Rheumatology, Volume 60, Issue 1, January 2021, Pages 125–131, https://doi.org/10.1093/rheumatology/keaa214
Glucocorticoid use is associated with an increased risk of hypertension
Rheumatology, Volume 60, Issue 1, January 2021, Pages 132–139, https://doi.org/10.1093/rheumatology/keaa209
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study
Rheumatology, Volume 60, Issue 1, January 2021, Pages 140–146, https://doi.org/10.1093/rheumatology/keaa237
Initial analgesic prescriptions for osteoarthritis in the United Kingdom, 2000–2016
Rheumatology, Volume 60, Issue 1, January 2021, Pages 147–159, https://doi.org/10.1093/rheumatology/keaa244
Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study
Rheumatology, Volume 60, Issue 1, January 2021, Pages 160–169, https://doi.org/10.1093/rheumatology/keaa210
Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study
Rheumatology, Volume 60, Issue 1, January 2021, Pages 170–178, https://doi.org/10.1093/rheumatology/keaa321
Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS)
Rheumatology, Volume 60, Issue 1, January 2021, Pages 179–187, https://doi.org/10.1093/rheumatology/keaa252
The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study
Rheumatology, Volume 60, Issue 1, January 2021, Pages 188–195, https://doi.org/10.1093/rheumatology/keaa262
The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial
Rheumatology, Volume 60, Issue 1, January 2021, Pages 196–206, https://doi.org/10.1093/rheumatology/keaa178
Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls
Rheumatology, Volume 60, Issue 1, January 2021, Pages 207–216, https://doi.org/10.1093/rheumatology/keaa267
Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4)
Rheumatology, Volume 60, Issue 1, January 2021, Pages 217–223, https://doi.org/10.1093/rheumatology/keaa247
Immune responses after influenza vaccination in patients of primary Sjögren’s syndrome
Rheumatology, Volume 60, Issue 1, January 2021, Pages 224–230, https://doi.org/10.1093/rheumatology/keaa243
Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children
Rheumatology, Volume 60, Issue 1, January 2021, Pages 231–238, https://doi.org/10.1093/rheumatology/keaa299
Ultrasound for the diagnosis of gout—the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group
Rheumatology, Volume 60, Issue 1, January 2021, Pages 239–249, https://doi.org/10.1093/rheumatology/keaa366
Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease
Rheumatology, Volume 60, Issue 1, January 2021, Pages 250–255, https://doi.org/10.1093/rheumatology/keaa322
Efficacy and safety of Sandoz biosimilar rituximab for active rheumatoid arthritis: 52-week results from the randomized controlled ASSIST-RA trial
Rheumatology, Volume 60, Issue 1, January 2021, Pages 256–262, https://doi.org/10.1093/rheumatology/keaa234
Diagnostic value of anti-CD74 antibodies in early and late axial spondyloarthritis and its relationship to disease activity
Rheumatology, Volume 60, Issue 1, January 2021, Pages 263–268, https://doi.org/10.1093/rheumatology/keaa292
Assessment of radiographic sacroiliitis in anteroposterior lumbar vs conventional pelvic radiographs in axial spondyloarthritis
Rheumatology, Volume 60, Issue 1, January 2021, Pages 269–276, https://doi.org/10.1093/rheumatology/keaa260
A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis: a cost-effectiveness analysis
Rheumatology, Volume 60, Issue 1, January 2021, Pages 277–287, https://doi.org/10.1093/rheumatology/keaa309
Femoral vein wall thickness measurement: A new diagnostic tool for Behçet’s disease
Rheumatology, Volume 60, Issue 1, January 2021, Pages 288–296, https://doi.org/10.1093/rheumatology/keaa264
Elevated circulating pro-inflammatory low-density granulocytes in adult-onset Still’s disease
Rheumatology, Volume 60, Issue 1, January 2021, Pages 297–303, https://doi.org/10.1093/rheumatology/keaa324
Neutrophil-derived lipocalin-2 in adult-onset Still’s disease: a novel biomarker of disease activity and liver damage
Rheumatology, Volume 60, Issue 1, January 2021, Pages 304–315, https://doi.org/10.1093/rheumatology/keaa368
Determinants of the patient global assessment of well-being in early axial spondyloarthritis: 5-year longitudinal data from the DESIR cohort
Rheumatology, Volume 60, Issue 1, January 2021, Pages 316–321, https://doi.org/10.1093/rheumatology/keaa353
Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity
Rheumatology, Volume 60, Issue 1, January 2021, Pages 322–332, https://doi.org/10.1093/rheumatology/keaa305
Predictors of persistent inflammation in familial Mediterranean fever and association with damage
Rheumatology, Volume 60, Issue 1, January 2021, Pages 333–339, https://doi.org/10.1093/rheumatology/keaa378
A clinical and radiographic comparison of patients with psoriatic arthritis from different ethnic backgrounds
Rheumatology, Volume 60, Issue 1, January 2021, Pages 340–345, https://doi.org/10.1093/rheumatology/keaa298
Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study
Rheumatology, Volume 60, Issue 1, January 2021, Pages 346–352, https://doi.org/10.1093/rheumatology/keaa327
The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice
Rheumatology, Volume 60, Issue 1, January 2021, Pages 353–358, https://doi.org/10.1093/rheumatology/keaa483
Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases
Rheumatology, Volume 60, Issue 1, January 2021, Pages 359–365, https://doi.org/10.1093/rheumatology/keaa416
Telemedicine in rheumatology: a reliable approach beyond the pandemic
Rheumatology, Volume 60, Issue 1, January 2021, Pages 366–370, https://doi.org/10.1093/rheumatology/keaa554
Serum urate is related to subclinical inflammation in asymptomatic hyperuricaemia
Rheumatology, Volume 60, Issue 1, January 2021, Pages 371–379, https://doi.org/10.1093/rheumatology/keaa425
Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remission
Rheumatology, Volume 60, Issue 1, January 2021, Pages 380–391, https://doi.org/10.1093/rheumatology/keaa496
The impact of COVID-19 on rheumatology practice across Africa
Rheumatology, Volume 60, Issue 1, January 2021, Pages 392–398, https://doi.org/10.1093/rheumatology/keaa600
Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study
Rheumatology, Volume 60, Issue 1, January 2021, Pages 399–407, https://doi.org/10.1093/rheumatology/keaa587
BASIC AND TRANSLATIONAL SCIENCE
Inhibition of hepatocyte growth factor/c-Met signalling abrogates joint destruction by suppressing monocyte migration in rheumatoid arthritis
Rheumatology, Volume 60, Issue 1, January 2021, Pages 408–419, https://doi.org/10.1093/rheumatology/keaa310
Splicing factor SRSF1 limits IFN-γ production via RhoH and ameliorates experimental nephritis
Rheumatology, Volume 60, Issue 1, January 2021, Pages 420–429, https://doi.org/10.1093/rheumatology/keaa300
LncRNA-H19 silencing suppresses synoviocytes proliferation and attenuates collagen-induced arthritis progression by modulating miR-124a
Rheumatology, Volume 60, Issue 1, January 2021, Pages 430–440, https://doi.org/10.1093/rheumatology/keaa395
Serum amyloid A1 genotype associates with adult-onset familial Mediterranean fever in patients homozygous for mutation M694V
Rheumatology, Volume 60, Issue 1, January 2021, Pages 441–444, https://doi.org/10.1093/rheumatology/keaa452
Idiopathic multicentric Castleman disease with novel heterozygous Ile729Met mutation in exon 10 of familial Mediterranean fever gene
Rheumatology, Volume 60, Issue 1, January 2021, Pages 445–450, https://doi.org/10.1093/rheumatology/keaa269
Distinct features between HLA-DR+ and HLA-DR− PD-1hi CXCR5– T peripheral helper cells in seropositive rheumatoid arthritis
Rheumatology, Volume 60, Issue 1, January 2021, Pages 451–460, https://doi.org/10.1093/rheumatology/keaa417
LETTERS TO THE EDITOR
OTHERS
Disease activity is associated with spinal radiographic progression in axial spondyloarthritis independently of exposure to tumour necrosis factor inhibitors
Rheumatology, Volume 60, Issue 1, January 2021, Pages 461–462, https://doi.org/10.1093/rheumatology/keaa564
The changing epidemiology of inpatient gout and associated mortality: a 17-year national study
Rheumatology, Volume 60, Issue 1, January 2021, Pages 462–465, https://doi.org/10.1093/rheumatology/keaa523
Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients
Rheumatology, Volume 60, Issue 1, January 2021, Pages 465–467, https://doi.org/10.1093/rheumatology/keaa738
Improving patient care through a collaborative effort in the Leeds Combined Psoriatic Service: an effective provision of multi-specialty input
Rheumatology, Volume 60, Issue 1, January 2021, Pages 467–470, https://doi.org/10.1093/rheumatology/keaa598
CLINICAL VIGNETTES
Calcinosis cutis universalis in dermatopathic dermatomyositis
Rheumatology, Volume 60, Issue 1, January 2021, Page 470, https://doi.org/10.1093/rheumatology/keaa331
Neck pain in rheumatoid arthritis: a look beyond cervical spine involvement
Rheumatology, Volume 60, Issue 1, January 2021, Page 471, https://doi.org/10.1093/rheumatology/keaa308
Pseudo mechanic’s hand—a pointer to alkaptonuria
Rheumatology, Volume 60, Issue 1, January 2021, Page 472, https://doi.org/10.1093/rheumatology/keaa342
Successful treatment of refractory mandibular lesions in SAPHO syndrome with secukinumab
Rheumatology, Volume 60, Issue 1, January 2021, Pages 473–474, https://doi.org/10.1093/rheumatology/keaa352
Lupus with abdominal pain
Rheumatology, Volume 60, Issue 1, January 2021, Page 475, https://doi.org/10.1093/rheumatology/keaa384
Hemifacial erythema: an unusual manifestation of lupus erythematosus tumidus
Rheumatology, Volume 60, Issue 1, January 2021, Page 476, https://doi.org/10.1093/rheumatology/keaa409
Looking at the lobule-importance of ears and years in rheumatology
Rheumatology, Volume 60, Issue 1, January 2021, Pages 477–478, https://doi.org/10.1093/rheumatology/keaa426
Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection
Rheumatology, Volume 60, Issue 1, January 2021, Pages 479–480, https://doi.org/10.1093/rheumatology/keaa689
CORRIGENDUM
Corrigendum to: Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis
Rheumatology, Volume 60, Issue 1, January 2021, Page 481, https://doi.org/10.1093/rheumatology/keaa501
PUBLISHED ONLINE ONLY
CASE REPORTS
Atypical juvenile dermatomyositis complicated by systemic capillary leak syndrome: case report and review of the literature
Rheumatology, Volume 60, Issue 1, January 2021, Pages e1–e2, https://doi.org/10.1093/rheumatology/keaa406
HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease
Rheumatology, Volume 60, Issue 1, January 2021, Pages e3–e4, https://doi.org/10.1093/rheumatology/keaa362
PR3-ANCA associated retinal vasculitis and atrial myxoma
Rheumatology, Volume 60, Issue 1, January 2021, Pages e5–e6, https://doi.org/10.1093/rheumatology/keaa263
Splice-site mutation in COPA gene and familial arthritis – a new frontier
Rheumatology, Volume 60, Issue 1, January 2021, Pages e7–e9, https://doi.org/10.1093/rheumatology/keaa354
Successful treatment of coronary artery aneurysm with infliximab in a Behçet’s disease patient
Rheumatology, Volume 60, Issue 1, January 2021, Pages e10–e11, https://doi.org/10.1093/rheumatology/keaa365
A case of Behçet’s syndrome initially presenting as recurrent neck pain
Rheumatology, Volume 60, Issue 1, January 2021, Pages e12–e13, https://doi.org/10.1093/rheumatology/keaa376
Immune-checkpoint kinetics for T cells in anti-MDA5 positive interstitial lung disease
Rheumatology, Volume 60, Issue 1, January 2021, Pages e14–e16, https://doi.org/10.1093/rheumatology/keaa412
Ureaplasma parvum bacterial arthritis of the elbow in a patient with rheumatoid arthritis treated with rituximab
Rheumatology, Volume 60, Issue 1, January 2021, Pages e17–e18, https://doi.org/10.1093/rheumatology/keaa358
A new diagnosis of systemic capillary leak syndrome in a patient with COVID-19
Rheumatology, Volume 60, Issue 1, January 2021, Pages e19–e20, https://doi.org/10.1093/rheumatology/keaa606
A case of psoriatic arthritis triggered by SARS-CoV-2 infection
Rheumatology, Volume 60, Issue 1, January 2021, Pages e21–e23, https://doi.org/10.1093/rheumatology/keaa691
MATTERS ARISING
Comment on: Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
Rheumatology, Volume 60, Issue 1, January 2021, Pages e24–e25, https://doi.org/10.1093/rheumatology/kez670
Comment on: The impact of smoking on prevalence of psoriasis and psoriatic arthritis
Rheumatology, Volume 60, Issue 1, January 2021, Page e26, https://doi.org/10.1093/rheumatology/keaa555
Comment on: The impact of smoking on prevalence of psoriasis and psoriatic arthritis: reply
Rheumatology, Volume 60, Issue 1, January 2021, Page e27, https://doi.org/10.1093/rheumatology/keaa559
Comment on: ‘It can’t be zero!’ Difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study
Rheumatology, Volume 60, Issue 1, January 2021, Pages e28–e29, https://doi.org/10.1093/rheumatology/keaa489
Comment on: ‘It can’t be zero!’ difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study: reply
Rheumatology, Volume 60, Issue 1, January 2021, Pages e30–e31, https://doi.org/10.1093/rheumatology/keaa488
Comment on: Equal rights in autoimmunity: is Sjögren's syndrome ever ‘secondary’?
Rheumatology, Volume 60, Issue 1, January 2021, Pages e32–e33, https://doi.org/10.1093/rheumatology/keaa633
Comment on: Equal rights in autoimmunity: is Sjögren's syndrome ever ‘secondary’?: reply
Rheumatology, Volume 60, Issue 1, January 2021, Page e34, https://doi.org/10.1093/rheumatology/keaa631
Comment on: The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity
Rheumatology, Volume 60, Issue 1, January 2021, Pages e35–e37, https://doi.org/10.1093/rheumatology/keaa729
Comment on: The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity: reply
Rheumatology, Volume 60, Issue 1, January 2021, Page e38, https://doi.org/10.1093/rheumatology/keaa714
